Skip to main content

Table 1 miRNAs showing > 3-fold expression change following treatment with EGCG in paclitaxel-exposed HDP cells

From: Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells

miRNA Change relative to controls Direction of regulation chr. miRNA Change relative to controls Direction of regulation chr.
hsa-miR-3663-3p 293.53 Up chr10 hsa-miR-500a-5p 105.14 Down chrX
hsa-miR-1181 241.98 Up chr19 hsa-miR-299-3p 102.72 Down chr14
hsa-miR-3613-3p 188.92 Up chr13 hsa-miR-140-5p 97.50 Down chr16
hsa-miR-1281 177.19 Up chr22 hsa-miR-193a-5p 73.05 Down chr17
hsa-miR-1539 169.23 Up chr18 hsa-miR-34a-3p 61.13 Down chr1
hsa-miR-125a-3p 159.16 Up chr19 hsa-miR-432-5p 60.05 Down chr14
hsa-miR-4271 158.48 Up chr3 hsa-miR-204-5p 56.88 Down chr9
hsa-miR-550a-5p 156.32 Up chr7 hsa-miR-485-3p 55.67 Down chr14
hsa-miR-642b-3p 142.71 Up chr19 hsa-miR-140-3p 55.23 Down chr16
hsa-miR-23c 134.49 Up chrX hsa-miR-409-5p 54.21 Down chr14
hsa-let-7f-1-3p 108.08 Up chr9 hsa-miR-146a-5p 52.69 Down chr5
hsa-miR-874 96.40 Up chr5 hsa-miR-423-5p 50.69 Down chr17
hsa-miR-33b-3p 88.74 Up chr17 hsa-miR-17-3p 50.49 Down chr13
hsa-miR-3180-5p 76.65 Up chr16 hsa-miR-487a 47.24 Down chr14
hsa-miR-150-3p 65.94 Up chr19 hsa-miR-450a-5p 47.14 Down chrX
hsa-miR-129-1-3p 64.80 Up chr7 hsa-miR-138-2-3p 45.41 Down chr16
hsa-miR-1249 63.67 Up chr22 hsa-miR-128 44.19 Down chr2
hsa-miR-3679-3p 60.74 Up chr2 hsa-miR-28-5p 43.34 Down chr3
hsa-miR-767-3p 34.07 Up chrX hsa-miR-431-5p 43.33 Down chr14
hsa-miR-3656 3.60 Up chr11 hsa-miR-146b-5p 43.22 Down chr10
hsa-miR-221-5p 132.32 Down chrX hsa-miR-4317 38.84 Down chr18
hsa-miR-374b 124.96 Down chrX hsa-miR-324-5p 38.47 Down chr17
hsa-miR-590-5p 122.52 Down chr7 hsa-miR-370 37.81 Down chr14
hsa-miR-4306 116.09 Down chr13 hsa-miR-16-2-3p 22.41 Down chr3
  1. Chr. chromosome